Filing Details
- Accession Number:
- 0001437749-13-012117
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-09-18 21:43:21
- Reporting Period:
- 2013-07-19
- Filing Date:
- 2013-09-18
- Accepted Time:
- 2013-09-18 21:43:21
- Original Submission Date:
- 2013-07-23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1484478 | Furiex Pharmaceuticals Inc. | FURX | Pharmaceutical Preparations (2834) | 271197863 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1492646 | Frances Gail Mcintyre | C/O Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150 Morrisville NC 27560 | Senior Vice President-Research | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-07-19 | 20,000 | $40.00 | 17,868 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was pursuant to a Rule 10b5-1 Sales Plan, which is intended to comply with Rule 10b5-1.